Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Randomized comparison of aspirin, aspirin + warfarin and aspirin + ticlopidine following stenting

March 5, 1999

Platelet aggregation inhibitors in development at SmithKline Beecham

March 4, 1999

FDA grants priority review to Boehringer Ingelheim's new stroke therapy

March 4, 1999

Vasoflux is superior to other anticoagulants due to its unique mechanism of action

March 3, 1999

Corvas reacquires rights to injectable anticoagulant from Schering-Plough

March 2, 1999

Emisphere Technologies updates oral heparin development program

March 2, 1999

European CPMP recommends approval of Integrilin for acute coronary syndrome

March 1, 1999

Merck & Co.'s new thrombin inhibitors

March 1, 1999

Antiplatelet agents under research at Monsanto

March 1, 1999

Spotlight update: fibrinogen (gpIIb/IIIa) receptor antagonists

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...